Prihlásiť sa Zaregistrujte sa zadarmo

Net debt/EBITDA spoločnosti Acasti Pharma Inc

Aká je hodnota metriky Net debt/EBITDA spoločnosti Acasti Pharma Inc?

Hodnota metriky Net debt/EBITDA spoločnosti Acasti Pharma Inc je 3.26

Aká je definícia metriky Net debt/EBITDA?



The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.

The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.

Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization

Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.

Net debt/EBITDA spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Acasti Pharma Inc

Čomu sa venuje spoločnosť Acasti Pharma Inc?

acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.

Firmy s metrikou net debt/ebitda podobnou spoločnosti Acasti Pharma Inc